US proton therapy market has potential to surpass US$ 16 Billion by 2024

Access full Research:
https://www.renub.com/united-states-proton-therapy-market-and-forecast-reimbursement-policy-patients-treated-at-proton-therapy-centers-1045-p.php

Get Free Customization in this Report

United States proton therapy market has potential to surpass US$ 16 Billion by the end of 2024. In current outlook United States captures more than 40 percent of Proton Beam Therapy Facility worldwide. The growth of proton therapy center in United States is substantial and the number of new advanced proton therapy center would be launched in forecast time-frame. In United States, almost 14 centers are in development phase (either under-construction or planning phase) will further boost the market of proton therapy.

By 14 Cancer Types - United States Proton Therapy Market & Patients
In this report, we have done comprehensive analysis of proton therapy market and proton therapy patient numbers by 14 cancer/tumor types to understand which cancer type has more or less inclination towards proton therapy technology. In proton therapy, the frequency of patients is much higher in prostate cancer followed by pediatric cancer because of its compatibility and survival rate. The report covers 14 cancer types as follows: Central Nervous System Tumors, Lung Cancer, Pituitary Neoplasms Cancer, Pediatric Cancer Cases (Up to Age 18), Base of Skull / Axial Skeleton Cancer, Urinary Tract Cancer, Head and Neck Cancer, Gastrointestinal Tract Cancer, Intraocular Melanomas Cancer, Retroperitoneal Sarcoma Cancer, Breast Cancer, Female Pelvic Organs Cancer, Prostate Cancer & Other Cancer.

Request a free sample copy of the report: https://www.renub.com/contactus.php

Annually Treated Patient Database by Proton Therapy Center in United States

In this report, we have covered the number of proton therapy patients treated by each proton therapy center since their inception and till 2017 on annual basis. According to Renub Research findings, proton therapy center in United States efficiently manage the patients. Moreover they are also expanding their capacity, improving technical skills and changing minor technology for the treatment of more people simultaneously.

United States Reimbursement Policy regarding Proton Beam Therapy
In this report, we have done complete assessment on United States proton therapy reimbursement policies. We have divided the reimbursement policy into two sections; by patients and by manufacturer, stakeholder and institutions.

United States Proton Therapy Market, Patients by 14 Cancer Types (Central Nervous System Tumors, Intraocular Melanomas Cancer, Pituitary Neoplasms Cancer, Base of Skull / Axial Skeleton Cancer, Head and Neck Cancer, Lung Cancer, Retroperitoneal Sarcoma Cancer, Pediatric Cancer Cases (Up to Age 18), Gastrointestinal Tract Cancer, Urinary Tract Cancer, Female Pelvic Organs Cancer, Prostate Cancer, Breast Cancer & Other Cancer) Reimbursement Policies & Persons Treated at Centers is a report published by Renub Research. In this report we have studied the market in two parts a) Actual Market and b) Potential Market. The report also talks about list of all operational and future Proton Therapy centers; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.
a) Actual Market is the current market which is already present
b) Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year.

United States Proton Therapy Market has been analyzed from 6 View Points (2009 – 2024)
• Actual Market & Forecast
• Potential Market & Forecast
• By 14 Cancer Types – USA Proton Therapy Market
• Patient Numbers & Forecast
• Potential Patient Numbers & Forecast
• By 14 Cancer Types – USA Proton Therapy Patient Numbers

Cancer Types – Proton Therapy Market & Patient Numbers
1. Central Nervous System Tumors
2. Intraocular Melanomas Cancer
3. Pituitary Neoplasms Cancer
4. Base of Skull / Axial Skeleton Cancer
5. Head and Neck Cancer
6. Lung Cancer
7. Retroperitoneal Sarcoma Cancer
8. Pediatric Cancer Cases (Up to Age 18)
9. Gastrointestinal Tract Cancer
10. Urinary Tract Cancer
11. By Female Pelvic Organs Cancer
12. Prostate Cancer
13. Breast Cancer
14. Other Cancer

Key Companies Covered
1. IBA (Overview, Sales Analysis)
2. Varian Medical Systems (Overview, Sales Analysis)
3. Elekta (Overview, Sales Analysis)

Contact Us
Rajat Gupta
Sr. Marketing Manager
Email: info@renub.com
Phone: +1-678-302-0700
Web: www.renub.com

Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today's ultra-competitive markets.

225 Kristie Ln, Roswell, GA 30076, United States

This release was published on openPR.